© 1995 American Heart Association, Inc.
Articles |
Lipoprotein Lipase Mass and Activity in Plasma and Their Increase After Heparin Are Separate Parameters With Different Relations to Plasma Lipoproteins
From the King Gustaf V Research Institute, Karolinska Institute, and Departments of Cardiology (P.T.) and Internal Medicine, (F.K., A.H.), Karolinska Hospital, Stockholm, and the Department of Medical Biochemistry and Biophysics (G.O., T.O.), University of Umeå, Umeå, Sweden.
Correspondence to Dr Per Tornvall, King Gustaf V Research Institute, Karolinska Hospital, Karolinska Institute, S-171 76 Stockholm, Sweden.
Abstract Lipoprotein lipase (LPL) activity and mass in plasma and their increase after heparin administration were measured in 61 men who had suffered myocardial infarction before the age of 45 years and in 69 population-based age- and sex-matched control subjects without coronary heart disease to study the relations between these parameters in plasma and their correlations with plasma lipoproteins in subjects with a wide range of lipoprotein and LPL levels. There was a relatively large amount of LPL protein compared with LPL activity in preheparin plasma, indicating that the majority of circulating LPL is catalytically inactive. LPL mass and activity in postheparin plasma (postheparin minus preheparin values) were highly correlated, and the calculated mean specific activity (0.35 mU/ng) was in the range expected for catalytically active LPL. Hence, heparin releases mainly active LPL. The four LPL parameters (mass and activity in plasma and their increase after heparin administration) were not related to each other, except for postheparin plasma LPL mass and activity, and they showed different correlations with plasma lipoprotein lipid concentrations. There was a strong positive correlation between LPL mass in preheparin plasma and the HDL cholesterol level as well as weak negative relations to VLDL triglyceride and cholesterol concentrations in the patients. In contrast, preheparin LPL activity showed no correlation with the HDL cholesterol level but weak positive relations to VLDL triglyceride and cholesterol concentrations in the control subjects. Postheparin plasma LPL activity related positively to the HDL cholesterol level and negatively to the VLDL triglyceride concentration in the control subjects. Case subjects differed from control subjects in that they had higher preheparin plasma LPL activity and a tendency toward lower specific activity of postheparin plasma LPL. The different relations of the measured LPL parameters to plasma lipoproteins and the difference in preheparin plasma LPL activity between patients and control subjects might reflect a disturbance of the LPL system in the patients.
Key Words: lipoprotein lipase • plasma lipoproteins • coronary heart disease
This article has been cited by other articles:
 |
|
 |
|
  D. T. Chan, G. K. Dogra, A. B. Irish, E. M. Ooi, P. H. Barrett, D. C. Chan, and G. F. Watts Chronic kidney disease delays VLDL-apoB-100 particle catabolism: potential role of apolipoprotein C-III J. Lipid Res., December 1, 2009; 50(12): 2524 - 2531. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Hernandez Vallejo, M. Alqub, S. Luquet, C. Cruciani-Guglielmacci, P. Delerive, J.-M. Lobaccaro, A.-D. Kalopissis, J. Chambaz, M. Rousset, and J.-M. Lacorte Short-term adaptation of postprandial lipoprotein secretion and intestinal gene expression to a high-fat diet Am J Physiol Gastrointest Liver Physiol, April 1, 2009; 296(4): G782 - G792. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Rip, M. C. Nierman, C. J. Ross, J. W. Jukema, M. R. Hayden, J. J.P. Kastelein, E. S.G. Stroes, and J. A. Kuivenhoven Lipoprotein Lipase S447X: A Naturally Occurring Gain-of-Function Mutation Arterioscler Thromb Vasc Biol, June 1, 2006; 26(6): 1236 - 1245. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Rip, M. C. Nierman, N. J. Wareham, R. Luben, S. A. Bingham, N. E. Day, J. N.I. van Miert, B. A. Hutten, J. J.P. Kastelein, J. A. Kuivenhoven, et al. Serum Lipoprotein Lipase Concentration and Risk for Future Coronary Artery Disease: The EPIC-Norfolk Prospective Population Study Arterioscler Thromb Vasc Biol, March 1, 2006; 26(3): 637 - 642. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ibrahim, A. Djimet-Baboun, V. Pruneta-Deloche, C. Calzada, M. Lagarde, and G. Ponsin Transfer of very low density lipoprotein-associated phospholipids to activated human platelets J. Lipid Res., February 1, 2006; 47(2): 341 - 348. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Zhang, A. Lookene, G. Wu, and G. Olivecrona Calcium Triggers Folding of Lipoprotein Lipase into Active Dimers J. Biol. Chem., December 30, 2005; 280(52): 42580 - 42591. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Ricart-Jane, P. Cejudo-Martin, J. Peinado-Onsurbe, M. D. Lopez-Tejero, and M. Llobera Changes in lipoprotein lipase modulate tissue energy supply during stress J Appl Physiol, October 1, 2005; 99(4): 1343 - 1351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. F. Lewis and D. J. Rader New Insights Into the Regulation of HDL Metabolism and Reverse Cholesterol Transport Circ. Res., June 24, 2005; 96(12): 1221 - 1232. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Nasstrom, B. Stegmayr, J. Gupta, G. Olivecrona, and T. Olivecrona A single bolus of a low molecular weight heparin to patients on haemodialysis depletes lipoprotein lipase stores and retards triglyceride clearing Nephrol. Dial. Transplant., June 1, 2005; 20(6): 1172 - 1179. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. von Eynatten, J. G. Schneider, P. M. Humpert, G. Rudofsky, N. Schmidt, P. Barosch, A. Hamann, M. Morcos, J. Kreuzer, A. Bierhaus, et al. Decreased Plasma Lipoprotein Lipase in Hypoadiponectinemia: An association independent of systemic inflammation and insulin resistance Diabetes Care, December 1, 2004; 27(12): 2925 - 2929. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Lookene, L. Zhang, M. Hultin, and G. Olivecrona Rapid Subunit Exchange in Dimeric Lipoprotein Lipase and Properties of the Inactive Monomer J. Biol. Chem., November 26, 2004; 279(48): 49964 - 49972. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Park, P. G Jones, and W. S Harris Triacylglycerol-rich lipoprotein margination: a potential surrogate for whole-body lipoprotein lipase activity and effects of eicosapentaenoic and docosahexaenoic acids Am. J. Clinical Nutrition, July 1, 2004; 80(1): 45 - 50. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Sposito, P. A. Lemos, R. D. Santos, W. Hueb, C. G. C. Vinagre, E. Quintella, O. Carneiro, M. J. Chapman, J. A. F. Ramires, and R. C. Maranhao Impaired intravascular triglyceride lipolysis constitutes a marker of clinical outcome in patients with stable angina undergoing secondary prevention treatment: A long-term follow-up study J. Am. Coll. Cardiol., June 16, 2004; 43(12): 2225 - 2232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Pruneta-Deloche, A. Sassolas, G. M. Dallinga-Thie, F. Berthezene, G. Ponsin, and P. Moulin Alteration in lipoprotein lipase activity bound to triglyceride-rich lipoproteins in the postprandial state in type 2 diabetes J. Lipid Res., May 1, 2004; 45(5): 859 - 865. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kuang, M. Febbraio, C. Wagg, G. D. Lopaschuk, and J. R.B. Dyck Fatty Acid Translocase/CD36 Deficiency Does Not Energetically or Functionally Compromise Hearts Before or After Ischemia Circulation, March 30, 2004; 109(12): 1550 - 1557. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Pruneta, D. Autran, G. Ponsin, C. Marcais, L. Duvillard, B. Verges, F. Berthezene, and P. Moulin Ex Vivo Measurement of Lipoprotein Lipase-Dependent Very Low Density Lipoprotein (VLDL)-Triglyceride Hydrolysis in Human VLDL: An Alternative to the Postheparin Assay of Lipoprotein Lipase Activity? J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 797 - 803. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Stachon, A. Boning, H. Weisser, A. Laczkovics, G. Skipka, and M. Krieg Prognostic Significance of Low Serum Cholesterol after Cardiothoracic Surgery Clin. Chem., August 1, 2000; 46(8): 1114 - 1120. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ruge, M. Bergo, M. Hultin, G. Olivecrona, and T. Olivecrona Nutritional regulation of binding sites for lipoprotein lipase in rat heart Am J Physiol Endocrinol Metab, February 1, 2000; 278(2): E211 - E218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Olin, S. Potter-Perigo, P. H. R. Barrett, T. N. Wight, and A. Chait Lipoprotein Lipase Enhances the Binding of Native and Oxidized Low Density Lipoproteins to Versican and Biglycan Synthesized by Cultured Arterial Smooth Muscle Cells J. Biol. Chem., December 3, 1999; 274(49): 34629 - 34636. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Levak-Frank, W. Hofmann, P. H. Weinstock, H. Radner, W. Sattler, J. L. Breslow, and R. Zechner Induced mutant mouse lines that express lipoprotein lipase in cardiac muscle, but not in skeletal muscle and adipose tissue, have normal plasma triglyceride and high-density lipoprotein-cholesterol levels PNAS, March 16, 1999; 96(6): 3165 - 3170. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. van Bennekum, Y. Kako, P. H. Weinstock, E. H. Harrison, R. J. Deckelbaum, I. J. Goldberg, and W. S. Blaner Lipoprotein lipase expression level influences tissue clearance of chylomicron retinyl ester J. Lipid Res., March 1, 1999; 40(3): 565 - 574. [Abstract] [Full Text]
|
|
|
|
|
|
F. Karpe, T. Olivecrona, G. Olivecrona, J. S. Samra, L. K. M. Summers, S. M. Humphreys, and K. N. Frayn Lipoprotein lipase transport in plasma: role of muscle and adipose tissues in regulation of plasma lipoprotein lipase concentrations J. Lipid Res., December 1, 1998; 39(12): 2387 - 2393. [Abstract] [Full Text]
|
|
|
|
|
|
S. Levak-Frank, P. H. Weinstock, T. Hayek, R. Verdery, W. Hofmann, R. Ramakrishnan, W. Sattler, J. L. Breslow, and R. Zechner Induced Mutant Mice Expressing Lipoprotein Lipase Exclusively in Muscle Have Subnormal Triglycerides yet Reduced High Density Lipoprotein Cholesterol Levels in Plasma J. Biol. Chem., July 4, 1997; 272(27): 17182 - 17190. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Pruneta, P. Moulin, F. Labrousse, P.-J. Bondon, G. Ponsin, and F. Berthezene Characterization of a New Case of Autoimmune Type I Hyperlipidemia: Long-Term Remission under Immunosuppressive Therapy J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 791 - 796. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Nielsen, J. Brejning, R. Garcia, H. Zhang, M. R. Hayden, S. Vilaro, and J. Gliemann Segments in the C-terminal Folding Domain of Lipoprotein Lipase Important for Binding to the Low Density Lipoprotein Receptor-related Protein and to Heparan Sulfate Proteoglycans J. Biol. Chem., February 28, 1997; 272(9): 5821 - 5827. [Abstract] [Full Text] [PDF]
|
|